Oxygenta Pharmaceutical Peer Comparison

Oxygenta Pharmaceutical Ltd. stands out as a sector laggard, exhibiting negative financial metrics across growth, profitability, and valuation, with no revenues or profits, while peers demonstrate diverse strengths. Companies like Sun Pharmaceutical and Dr. Reddy's Laboratories show strong profitability and growth, contrasting sharply with Oxygenta's performance.

• • Oxygenta has negative PE and PBV ratios, indicating deep financial distress.
• • Sun Pharmaceutical leads in growth metrics with a 8.42% YoY revenue increase and a healthy EPS of 45.55.
• • Dr. Reddy's and Cipla are strong performers in profitability with ROE above 21%.

• • Sun Pharmaceutical Industries Ltd.: Highest revenue growth YoY (8.42%) and strong EPS (45.55) with a solid ROE (16.13%).
• • Dr. Reddy's Laboratories Ltd.: High profitability with an ROE of 21.76% and consistent revenue growth.
• • Cipla Ltd.: Strong growth trajectory with a YoY revenue increase of 13.28% and a competitive ROE of 16.63%.